Market Highlights

The global clinical trial supplies market is anticipated to grow from USD 4.1 billion by 2023 to USD 10.15 billion by 2033 at a CAGR of 9.49%.

Clinical Trial Supplies Market CAGR

2023-2033

CAGR OF

9.49%

Clinical Trial Supplies Market

The global demand for clinical trial supplies has been tremendously over from the past few years due to the high growth in the overall biopharmaceutical industry. 
The market includes products and services that make clinical trials management more effective and efficient. Clinical trials are research studies to find out whether a new drug, vaccine, medical treatment & strategy, medical devices or dietary supplements are safe, and efficient for humans. These are complex activities performed on human participants. A safe and secured clinical trial requires a robust supply chain management. The optimization of clinical trial supplies is the most vital part of any clinical trial. It helps to deliver the drug or the material that is to be studied, to the participants on time. The clinical trial supply chain includes manufacturing, packaging, storage & distribution, and temperature management of the investigational material.
This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the overall market. The historic years considered for the study are 2018-2021, the base year is 2022, the estimated year is 2023, and forecast period is 2023-2033.

Clinical Trial Supplies Market: Market dynamics

The global clinical trial supplies market is anticipated to witness steady growth rate during the forecast period. This is attributed to the growing prevalence of chronic diseases coupled with Increase in need of detection level of toxicity of the drug at the early stages. Also, increasing expenditure on R & D in biopharmaceutical and pharmaceutical sector and outsourcing of clinical trials due to harmonization of regulations across the globe are some of the driving factors of the market.
However, high cost of clinical trials and drug development is anticipated to hinder the market growth.

Clinical Trial Supplies Market: Segmental Analysis

Clinical Trial Supplies Market

By Phase

l

ll

lll

lV

The Market will Grow

At the CAGR of:

9.49%

The Forecast Market

Size for 2033 in USD:

$10.15B

The global clinical trial supplies market is segmented into Phase, drug type, service (manufacturing, packaging & logistics, distribution, storage, and solutions), therapeutic area, and region. 
Further, the phase segment is classified into l, ll, lll, and lV phases in the overall pharmaceutical industry. The phase III accounted for the largest share in the overall phase segment in 2019, which is expected to witness maximum CAGR during the forecast period. This is attributed to its lower rate of failure in the trial phase which also consumes the time in the whole process.

Clinical Trial Supplies Market

By Therapeutic Area

XX%

Oncology

Digestive System Diseases

Neurological & Mental Disorders

Blood Disorders

4.1

Total Market Size

USD (Billion), 2023

9.49%

CAGR

2023 - 2033

Based on service segment, the global market is segmented into manufacturing, packaging & logistics, distribution, storage, and solutions.
Based on therapeutic area segment, the market is classified into oncology, digestive system diseases, neurological & mental disorders, blood disorders, and others.

Clinical Trial Supplies Market: Geographical Analysis

Clinical Trial Supplies Market

By Region

The Market will Grow

At the CAGR of:

9.49%

The Forecast Market

Size for 2033 in USD:

$10.15B

Geographically, the market is classified into five different regions such as North America, Asia-Pacific, South America, Europe, and the Middle East & Africa.
North America region contributed to the major market share of the market. It is expected to continue dominance in the market during the forecast period, owing to the presence of contract research organisations in the region, increasing investments in R & D by pharmaceutical and biopharmaceutical companies. However, Asia-Pacific region is anticipated to grow at the highest growth rate during the forecast period, owing to huge number of patients coupled with less strict patient recruitment regulations.

Clinical Trial Supplies Market: Key Players

The leading players of the global clinical trial supplies market are Thermo Fisher Scientific, Inc. (US), PCI Services (US), Parexel International Corporation (US), Biocair (UK), O&M Movianto (US), Sharp Packaging Services (US), Catalent, Inc. (US), KLIFO A/S (Denmark), Bilcare Limited (India), and Alamc Group (UK).

Critical Questions Answered in the report

•    What are the key trends in the market?
•    How the market (and its various sub segments) has grown in last four years and what would be the growth rate in next five years?
•    What are the key strategies adopted by the major vendors to lead the market?
•    What is the market share of the top players?

Research Methodology

The research study extensively uses both secondary and primary research methodologies. More than 200 industry leaders from various phases of the value chain (demand side, supply side, resellers/distributors, and other independent consultants) were interviewed to gain crucial insights about this market and validate the research findings. Secondary sources referred for the research study include company websites, annual reports, paid database tools, investor presentations, webinars, blogs, news/journals, whitepapers, survey papers, associations, and government websites. All the collected data and insights were then processed using our proprietary data mining software that executes various algorithms to make projections for the forecast period.

Clinical Trial Supplies Market Scope: